These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 28906015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer.
    Tan HL, Nyarko A, Duan SL, Zhao YX, Chen P, He Q, Zhang ZJ, Chang S, Huang P.
    Front Endocrinol (Lausanne); 2022; 13():987906. PubMed ID: 36714580
    [Abstract] [Full Text] [Related]

  • 4. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
    Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, Guo N, Gao X.
    Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
    [Abstract] [Full Text] [Related]

  • 5. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis.
    Kim SS, Lee BJ, Lee JC, Kim SJ, Jeon YK, Kim MR, Huh JE, Mok JY, Kim BH, Kim YK, Kim IJ.
    Head Neck; 2011 Sep; 33(9):1272-7. PubMed ID: 21837696
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.
    Chen S, Niu C, Peng Q, Tang K.
    Front Endocrinol (Lausanne); 2021 Sep; 12():556851. PubMed ID: 33796065
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE, Ryu JS, Kim TY, Shong YK, Kim WB.
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Surgical management of papillary thyroid carcinoma coexisting with Hashimoto's disease: a single-center retrospective cohort study.
    Zhang D, Wu J, Chen L.
    Front Endocrinol (Lausanne); 2024 Feb; 15():1383945. PubMed ID: 39170744
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A nomogram based on the risk factors of cervical lymph node metastasis in papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.
    Miao H, Zhong J, Xing X, Sun J, Wu J, Wu C, Yuan Y, Zhou X, Wang H.
    Clin Hemorheol Microcirc; 2023 Feb; 85(3):235-247. PubMed ID: 37718783
    [Abstract] [Full Text] [Related]

  • 16. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.
    Qu N, Zhang L, Lin DZ, Ji QH, Zhu YX, Wang Y.
    Tumour Biol; 2016 Jun; 37(6):7685-92. PubMed ID: 26692097
    [Abstract] [Full Text] [Related]

  • 17. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
    Zhang Y, Dai J, Wu T, Yang N, Yin Z.
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis.
    Konturek A, Barczyński M, Nowak W, Wierzchowski W.
    Langenbecks Arch Surg; 2014 Feb; 399(2):229-36. PubMed ID: 24407910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.